Skip to main content
Clinical Trials/NCT02657941
NCT02657941
Terminated
Not Applicable

Early and Short Psycho-educational Lifestyle Intervention to Prevent Weight Gain Induced by Psychotropic Drugs in Adults With Severe Mental Illness: a Randomized Controlled Trial

Hôpital le Vinatier1 site in 1 country10 target enrollmentDecember 9, 2015
ConditionsSchizophrenia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
Hôpital le Vinatier
Enrollment
10
Locations
1
Primary Endpoint
Change in body weight (kg)
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

People with severe mental illness have an increased risk of somatic comorbidities such as metabolic syndrome, obesity, hypertension, dyslipidemia and diabetes mellitus, which induce an increased risk of early mortality, mainly because of cardiovascular diseases.

These high cardio-metabolic risks result of several factors such as lack of access to medical care, a poor and unbalanced nutrition, physical inactivity and smoking but they are also exacerbated by antipsychotic medications and anti-epileptic mood stabilizers prescribed to treat their psychiatric disorder.

These prevention and awareness interventions in lifestyle are most often implemented in ambulatory stabilized patients. Also weight gain occurs in the early months of treatment. The therapeutic education program evaluated in this study seeks to potentiate the effectiveness of these preventive measures through early awareness in hospitalized patients.

Finally, this study aims to compare the efficacy of two early and short programs on health behavior: first a program inspired by motivational interviewing and behavioral psychotherapy and secondly an exclusively educational program (information, formative assessment).

Detailed Description

This both psychoeducational programs have a common objective through different methods to promote early awareness of the lifestyle (physical activity and dietary balance) of hospitalized adult patients who receive a psychotropic medication that may cause increased morbidity cardiovascular mortality through excessive weight gain and development of metabolic syndrome. Both programs have the same number of sessions of the same duration (three weekly sessions of one hour); the same themes are addressed (risk of weight gain and cardiovascular risks induced by treatments, benefits of physical activity and of a balanced diet); only the psycho-educational methods differ. These programs are for patients with serious mental illness (mainly psychotic disorders and mood disorders), hospitalized in one of the four adult psychiatric units of the Eastern Sector of the Vinatier Hospital in Bron, France. Patients are treatment-naive or already under psychotropic drug(s) but a new antipsychotic or mood-stabilizer must have been started during this hospitalization. Patients are included on indication of their referring physician in hospital, as soon as their clinical status is compatible. They are randomized to one of two therapeutic educational groups. The two parallel modules of psycho-education are co-managed by two nurses specialized in psycho-education. The study is based on a module per month for 18 months. Patients included will receive three individual interviews with a nurse or psychiatrist: the first interview before module, the second after module and the third three months after module.

Registry
clinicaltrials.gov
Start Date
December 9, 2015
End Date
November 14, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hôpital le Vinatier
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Hospitalized patients in one of four adult psychiatric units of eastern pole of the Hospital Vinatier
  • man or woman
  • aged between 18 (major) and 45 years (age limit on inducing a cardiovascular risk)
  • receiving anti-psychotic medication or antiepileptic mood stabilizer introduced during this hospitalization: patients must be treatment-naive or already under psychotropic drug(s) since less than 10 years

Exclusion Criteria

  • aged over 45 years at inclusion
  • pregnancy or breastfeeding
  • patient suffering from a neurodegenerative disease
  • patient suffering from an eating disorder
  • patient with a BMI\> 30
  • patient treated for more than 10 years by anti-psychotic medication or antiepileptic mood stabilizer

Outcomes

Primary Outcomes

Change in body weight (kg)

Time Frame: Change from baseline after 3 months

Secondary Outcomes

  • Changes in waist circumference (cm)(Change from baseline after 3 months)
  • Appearance of a SBP (systolic blood pressure) greater than the pathological threshold (> 140 mmHg) or DBP (diastolic blood pressure) above the pathological level (> 90 mmHg)(Change from baseline after 3 months)
  • Appearance of HDL cholesterol below the pathological threshold (<0.40 g/l) and / or LDL cholesterol greater than the pathological threshold (> 2.20 g/l) and / or higher triglyceride pathological level (> 1.5 g/l)(Change from baseline after 3 months)
  • Appearance of a fasting blood glucose higher than pathological threshold defined by ANAES in 1999 (> 1.26 g/l on two samples)(Change from baseline after 3 months)
  • Increased motivation to participate in a non-hospital treatment group on food and cooking(Change from baseline after 3 months)
  • Increased motivation to participate in a non-hospital treatment group on physical activity or sport(Change from baseline after 3 months)
  • Improved knowledge of balance and food hygiene(Change from baseline after 3 months)

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
Effects on Physical and Mental Prognosis and Quality of Life of Elderly People With Depressive SymptomsDepression
NCT05852912Chang Gung Memorial Hospital240
Completed
Not Applicable
Exploring the Comorbidity Between Mental Disorders and General Medical ConditionsOrganic, Including Symptomatic, Mental DisordersSubstance UseSchizophreniaMood [Affective] DisordersNeurotic, Stress-related and Somatoform DisordersEating DisorderDisorders of Adult Personality and BehaviorMental RetardationDisorder of Psychological DevelopmentBehavioural DisorderHypertensionDyslipidemiasIschemic Heart DiseaseAtrial FibrillationHeart FailurePeripheral Occlusive DiseaseStrokeDiabetes MellitusThyroid DisorderGoutChronic Pulmonary DiseaseAllergyChronic GastritisChronic Liver DiseaseInflammatory Bowel DiseasesDiverticular Disease of Large IntestineChronic Kidney DiseasesProstate DisordersConnective Tissue DisorderOsteoporosisPainHIV/AIDSAnemiaCancerVision DisordersHearing DisordersMigraineEpilepsyParkinson DiseaseMultiple SclerosisNeuropathy
NCT03847753University of Aarhus5,940,299
Suspended
Not Applicable
Predictors of the Long-term Functional Benefits of a Pulmonary Rehabilitation Program?Chronic Obstructive Pulmonary Disease
NCT02528487Hopital du Sacre-Coeur de Montreal360
Completed
Not Applicable
Psychosomatic Risk ScreeningCardiovascular Diseases
NCT06651164Heidelberg University142
Completed
Not Applicable
Fitforlife- Exercise in Care of PsychosisPsychotic Disorders
NCT04239612Karolinska Institutet156